These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9642362)

  • 1. [The effect of MPS on LAK cell growth and its cytotoxic activity against laryngeal cancer (HEP-2)].
    Wang J; Zhu X; Chen J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):283-6. PubMed ID: 9642362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The study of effects of immunologic modifier on proliferation and cytotoxicity against HEP-2 of LAK cells in vitro].
    Han D; Zhu X; Zhang W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):287-9. PubMed ID: 10743094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
    Reiter Z; Taylor MW
    Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
    Wang ZP; Chen YR; Zheng RL; Lu JZ; Wang JJ
    Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro.
    Wang ZP; Zheng RL; Chen YR; Liu GD
    Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):522-4. PubMed ID: 10322910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor enhanced LAK cell cytotoxicities against human bladder neoplasm cells.
    Wang ZP; Duan GL; Chen YR; Qin DS; Liu GD; Niu HG
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):276-8. PubMed ID: 10452107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 killer cells: in vitro evaluation of combination with prothymosin alpha.
    López-Rodríguez JL; Cordero OJ; Sarandeses C; Viñuela J; Nogueira M
    Lymphokine Cytokine Res; 1994 Jun; 13(3):175-82. PubMed ID: 7948426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction of LAK cells by high density dialyzing culture device and its cytotoxicity].
    Kohgo Y; Kanisawa Y; Sakamaki S; Nojiri S; Ueno Y; Ito Y; Niitsu Y; Hosoi S; Sato S; Urushizaki I
    Hum Cell; 1988 Mar; 1(1):54-9. PubMed ID: 3154014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
    Wang Z; Cheng Y; Zheng R; Qin D; Liu G
    Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
    Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon-alpha and gamma on development of LAK activity from mononuclear cells in breast cancer patients.
    Kamamura Y; Takahashi K; Komaki K; Monden Y
    J Med Invest; 1998 Aug; 45(1-4):71-5. PubMed ID: 9864966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle assessment of adoptive transferred lymphokine activated killer cells.
    Watanabe R; Tanaka N; Naomoto Y; Moreira LF; Orita K
    Jpn J Clin Oncol; 1994 Apr; 24(2):59-65. PubMed ID: 8158860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Phytolacca acinosa polysaccharides I combined with interleukin-2 on the cytotoxicity of murine splenocytes against tumor cells.
    Wang HB; Chen WZ; Bao EJ; Zheng QY; Song HL; Fang J; Xu YX; Chen HS
    Yao Xue Xue Bao; 1995; 30(6):401-7. PubMed ID: 7572178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 and IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients.
    Verma V; Sharma V; Shrivastava SK; Nadkarni JJ
    J Exp Clin Cancer Res; 2000 Sep; 19(3):367-74. PubMed ID: 11144531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro].
    Li JF; Guo JW; Huang XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Apr; 16(4):224-6. PubMed ID: 9206247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
    Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study on cytotoxicity of lymphocytes from different tissues in laryngeal cancer].
    An W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(5):292-4, 314-5. PubMed ID: 8192933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell].
    Meng YG; Fu CY; Wang YZ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):535-7, 574. PubMed ID: 7835130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.